乳腺癌病史对TUBA-WISP-II研究中卵巢癌风险降低手术决策的影响
研究纳入1676名绝经前BRCA1/2致病性变异携带者,其中222名(13.2%)有乳腺癌病史。有乳腺癌病史者77.0%选择风险降低性输卵管切除术联合延迟卵巢切除术,无病史者为78.0%(P=.73)。有乳腺癌病史且确诊年龄在指南年龄范围内者更常选择风险降低性输卵管卵巢切除术(比值比6.2,95%置信区间1.9-19.9)。
要点
- 乳腺癌病史与风险降低手术类型偏好无显著关联(77.0%对78.0%,P=.73)。
- 乳腺癌确诊在指南年龄范围内者更常选择风险降低性输卵管卵巢切除术(比值比6.2)。
- 乳腺癌确诊早于BRCA1/2诊断者首次手术中位时间晚2年。
核心结论
- 乳腺癌病史与特定风险降低策略偏好无关。
- 乳腺癌确诊在指南年龄范围内者比确诊在指南年龄范围之前者更常选择风险降低性输卵管卵巢切除术。
研究设计与样本
- 研究为TUBA-WISP-II研究的一部分,纳入绝经前BRCA1/2致病性变异携带者,通过基于网络的问卷收集个人史和偏好风险降低策略。
- 共纳入1676名女性,其中222名(13.2%)有乳腺癌病史。
- 比较有和无乳腺癌病史女性首次风险降低手术类型和时机的差异,并对有乳腺癌病史女性选择风险降低性输卵管卵巢切除术的相关特征进行多变量分析。
主要发现
- 有乳腺癌病史女性中77.0%选择风险降低性输卵管切除术联合延迟卵巢切除术,无乳腺癌病史女性中为78.0%(P=.73)。
- 乳腺癌确诊早于BRCA1/2诊断者首次手术中位时间比同时确诊或BRCA1/2诊断在先者晚2年。
- 乳腺癌确诊在指南年龄范围内(BRCA1为35-40岁,BRCA2为40-45岁)者比确诊在指南年龄范围之前者更常选择风险降低性输卵管卵巢切除术(比值比6.2,95%置信区间1.9-19.9)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Female BRCA1/2 pathogenic variant carriers have an increased risk of breast and ovarian cancer. In the TUBA-WISP II study, women chose between standard risk-reducing salpingo-oophorectomy and risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer. At inclusion, a substantial proportion of the enrolled women had a history of breast cancer, which could affect decision-making. OBJECTIVE: This study aimed to describe decision-making regarding the type and timing of risk-reducing surgery between women with and without a history of breast cancer. STUDY DESIGN: Premenopausal BRCA1/2 pathogenic variant carriers completed Web-based questionnaires on their personal histories and preferred risk-reducing strategy. Differences in the type and timing of the first risk-reducing surgery between women with and without a history of breast cancer were assessed. A multivariate analysis was performed to examine personal, environmental, and breast cancer-related characteristics associated with the choice of risk-reducing salpingo-oophorectomy among women with a history of breast cancer. RESULTS: This study included 1676 women, among whom 222 (13.2%) had a history of breast cancer. Of note, 77.0% of women with a history of breast cancer chose risk-reducing salpingectomy with delayed oophorectomy compared with 78.0% of women without a history of breast cancer (P=.73). Individuals with breast cancer before their BRCA1/2 diagnosis had their first surgery at a median of 2 years later than those who were diagnosed simultaneously or had their BRCA1/2 diagnosis first. Women diagnosed with breast cancer within the guideline age range for completing risk-reducing salpingo-oophorectomy (35-40 years for BRCA1 and 40-45 years for BRCA2) more often chose risk-reducing salpingo-oophorectomy than those before the guideline age range (odds ratio, 6.2 [95% confidence interval, 1.9-19.9]). CONCLUSION: A history of breast cancer was not associated with a preference for a specific risk-reducing strategy. Women diagnosed with breast cancer within the guideline age range more often chose risk-reducing salpingo-oophorectomy than those diagnosed with breast cancer before the guideline age range.
引用
- Gootzen TA, Steenbeek MP, van Gelder MMHJ, et al. Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. Am J Obstet Gynecol. 2025. PMID: 40532962. doi:10.1016/j.ajog.2025.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。